ReviewInternational journal of cardiology. Heart & vasculature2024

Efficacy and safety of Mavacamten for symptomatic Hypertrophic cardiomyopathy - an updated Meta-Analysis of randomized controlled trials.

Irfan Ullah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.